About polypeptide group ag - PLYGF
PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries. It operates through the following business areas: Custom Projects, Contract Manufacturing, and Generics and Cosmetics. The Custom Projects business area includes manufacturing of custom research-grade peptides and oligonucleotides for use in pre-clinical and clinical development as well as for regulatory and scientific studies. The Contract Manufacturing business area focuses on peptides for commercial stage peptide therapeutics, at scale, in commercial batches and in accordance with current Good Manufacturing Practice (cGMP) requirements. The Generics and Cosmetics business area is involved in peptide-based generics for the human and veterinary market, produced on an industrial scale following cGMP guidelines. The company was founded in 1952 and is headquartered in Baar, Switzerland.
PLYGF At a Glance
PolyPeptide Group AG
Neuhofstrasse 24
Baar, Zug 6340
| Phone | 41-43-502-05-80 | Revenue | 364.30M | |
| Industry | Biotechnology | Net Income | -21,162,197.96 | |
| Sector | Health Technology | 2024 Sales Growth | 5.181% | |
| Fiscal Year-end | 12 / 2025 | Employees | 1,362 | |
| View SEC Filings |
PLYGF Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | N/A |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | N/A |
PLYGF Efficiency
| Revenue/Employee | 267,477.822 |
| Income Per Employee | -15,537.59 |
| Receivables Turnover | 3.274 |
| Total Asset Turnover | 0.472 |
PLYGF Liquidity
| Current Ratio | 1.687 |
| Quick Ratio | 0.935 |
| Cash Ratio | 0.351 |
PLYGF Profitability
| Gross Margin | 10.728 |
| Operating Margin | -2.333 |
| Pretax Margin | -5.82 |
| Net Margin | -5.809 |
| Return on Assets | -2.74 |
| Return on Equity | -5.35 |
| Return on Total Capital | -4.528 |
| Return on Invested Capital | -4.568 |
PLYGF Capital Structure
| Total Debt to Total Equity | 26.345 |
| Total Debt to Total Capital | 20.852 |
| Total Debt to Total Assets | 12.44 |
| Long-Term Debt to Equity | 16.348 |
| Long-Term Debt to Total Capital | 12.939 |